HT
GOSS icon

HAP Trading’s Gossamer Bio GOSS Stock Holding History

HAP Trading’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-315
Closed -$16K – 1853
2022
Q2 		$16K Buy
+315
New +$195K ﹤0.01% 1373
2020
Q3 		– Sell
-336
Closed -$6K – 1700
2020
Q2 		$6K Sell
336
-44
-12% -$44.3K ﹤0.01% 1521
2020
Q1 		$76K Buy
+380
New +$397K 0.01% 713

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

HAP Trading's GOSS Position: Q4 2019 in Review

HAP Trading sold out of Gossamer Bio (GOSS) in Q4 2019, closing a stake of 271 shares — an estimated $364K sold.

HAP Trading first reported a position in GOSS in Q3 2019 and held it in 1 quarter. The position peaked at $364K in Q3 2019. 86 funds tracked by Wall St. Rank hold GOSS as of Q4 2019.

  • HAP Trading reported no remaining Gossamer Bio position as of Q4 2019 after selling out during the quarter.
  • HAP Trading sold 271 Gossamer Bio shares in Q4 2019, an estimated $364K.
  • HAP Trading first reported a position in Gossamer Bio in Q3 2019 and held it in 1 quarter.
  • HAP Trading's Gossamer Bio position peaked at $364K in Q3 2019.
  • 86 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.